Skip to Main Content

Paper Details

Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cells.
Blood
8
2023
-, CML, CML hematopoietic stem and progenitor cell, CML stem cell, CML stem cells, CML-committed progenitors, HIF-1, HIF-1 protein, TKI, TKI-treated stem cells, Tyrosine, Tyrosine kinase, chronic myelogenous leukemia, dormant CML stem cells, human, leukemia, leukemia stem cells, metabolic gene, mouse, murine, murine and human CML stem cells, oxygen, primitive, primitive CML stem cells, primitive, quiescent leukemia stem cells, stem cells, transcription factors, treated, tricarboxylic acid, tyrosine, tyrosine kinase
Author NameAffiliation
David K CrossmanUniversity of Alabama at Birmingham
David K CrossmanUniversity of Alabama at Birmingham
Robert S WelnerUniversity of Alabama at Birmingham
Robert S WelnerUniversity of Alabama at Birmingham
Victor M Darley-UsmarUniversity of Alabama at Birmingham
Victor M Darley-UsmarUniversity of Alabama at Birmingham
Jason W LocasaleDuke University School of Medicine
  • 1 - 7

Datasets

Release 1.2